Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Jonnyboy85on Mar 17, 2021 11:34am
91 Views
Post# 32816415

RE:RE:RE:RE:RE:ARISTOTLE....

RE:RE:RE:RE:RE:ARISTOTLE....Yep, and if you ask me, calling the vote early is a power move. Why would he call the vote early, put his job on the line immediately after he set a dealine for aristotle launch and Q4 rev reporting.

&nbsp;<br /> <br /> <br />
LithLover wrote: The 29th is the date of record.&nbsp; Meaning shareholders who hold stock on March 29 will get the documents from their brokers.&nbsp;&nbsp;The actual vote and documents you send in in April/early May prior to the May 17 meeting.<br /> <br /> So in effect if the launch is delayed or the launch is a bust, when we return our documents in April it could be a concern for him.<br /> <br /> So that is why many are saying he needs to launch before the 29th and launch with a full comprehensive update and partnership agreements etc so any shareholders on the 29th will be happy shareholders voting for the board and with the company and not a mob with pitch forks.<br /> <br /> <blockquote class="BBQuote"> <div> <cite>molotov420 wrote:</cite> yep all too familiar with that song and dance...hence my concern. If the vote is moved to March 29 before Q1 ends, could he be trying to secure his position before any anouncement (launch or delay) is made? Also I havent received any documentation to vote....</div> </blockquote> <br /> <br />
<br /> <br />
<< Previous
Bullboard Posts
Next >>